Induction of apoptosis by telomere 3' overhang-specific DNA

Exp Cell Res. 2002 Jun 10;276(2):185-93. doi: 10.1006/excr.2002.5531.

Abstract

Telomeres are tandem repeats of a specific TTAGGG nucleotide sequence at the ends of chromosomes. Telomere shortening is proposed to act as a biological clock and cancer prevention mechanism by inducing a nonproliferative, senescent phenotype after a limited number of cellular divisions. Recent evidence also suggests that telomere disruption can trigger apoptosis in certain cell types, mimicking a major cellular response to DNA damage. Here, we show that addition of DNA oligonucleotides homologous to the telomere 3' overhang sequence causes lymphocytic (Jurkat) cells to undergo apoptosis, as described for lymphocytes following telomere loop disruption. We further implicate the p53 tumor suppressor and transcription factor, as well as the p53 homolog p73 and the E2F1 transcription factor, in mediating the apoptotic response. We propose that exposure of the telomere 3' overhang due to opening of the normal telomere loop structure is a physiologic signal for these DNA damage-like responses in vivo and that oligonucleotides partially or completely homologous to the telomere overhang mimic this signal in the absence of DNA damage or telomere disruption.

MeSH terms

  • 3' Flanking Region / drug effects
  • 3' Flanking Region / genetics*
  • Apoptosis / drug effects
  • Apoptosis / genetics*
  • Base Sequence / drug effects
  • Base Sequence / genetics
  • Cell Cycle Proteins*
  • Cell Division / drug effects
  • Cell Division / genetics*
  • Cell Transformation, Neoplastic / drug effects
  • Cell Transformation, Neoplastic / genetics
  • Cell Transformation, Neoplastic / metabolism
  • Cellular Senescence / drug effects
  • Cellular Senescence / genetics*
  • DNA / genetics*
  • DNA / pharmacology
  • DNA Damage / drug effects
  • DNA Damage / genetics
  • DNA-Binding Proteins / drug effects
  • DNA-Binding Proteins / genetics
  • DNA-Binding Proteins / metabolism
  • Dose-Response Relationship, Drug
  • E2F Transcription Factors
  • E2F1 Transcription Factor
  • Eukaryotic Cells / drug effects
  • Eukaryotic Cells / metabolism*
  • Genes, Tumor Suppressor
  • Humans
  • Jurkat Cells
  • Nuclear Proteins / drug effects
  • Nuclear Proteins / genetics
  • Nuclear Proteins / metabolism
  • Oligonucleotides / genetics
  • Oligonucleotides / pharmacology
  • S Phase / drug effects
  • S Phase / genetics
  • Telomere / drug effects
  • Telomere / genetics*
  • Telomere / metabolism
  • Thymidine / genetics
  • Thymidine / pharmacology
  • Transcription Factors / drug effects
  • Transcription Factors / genetics
  • Transcription Factors / metabolism
  • Tumor Protein p73
  • Tumor Suppressor Protein p53 / genetics
  • Tumor Suppressor Protein p53 / metabolism
  • Tumor Suppressor Proteins
  • Up-Regulation / drug effects
  • Up-Regulation / genetics

Substances

  • Cell Cycle Proteins
  • DNA-Binding Proteins
  • E2F Transcription Factors
  • E2F1 Transcription Factor
  • E2F1 protein, human
  • Nuclear Proteins
  • Oligonucleotides
  • TP73 protein, human
  • Transcription Factors
  • Tumor Protein p73
  • Tumor Suppressor Protein p53
  • Tumor Suppressor Proteins
  • DNA
  • Thymidine